ReviewImmuno-oncology technology2022
CD47-SIRPα-targeted therapeutics: status and prospects.
R Maute et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
123 papers cite itlatest 60 shown
this papercites it
ReviewImmuno-oncology technology2022
R Maute et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.